Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
(-)
News
(50)
Filter by content year
2024
(4)
2023
(8)
2022
(8)
2021
(4)
2020
(26)
Filter by form group
Filter by category
(-)
Financial
(50)
(-)
Other
(50)
All
(42)
Events
(16)
Collaborators
(10)
Clinical
(1)
Filter by category
Search
News
Pfizer und BioNTech geben potenzielle Liefervereinbarung mit der EU über 200 Millionen Dosen von mRNA-basierten Impfstoffkandidaten gegen SARS-CoV-2 bekannt
News
Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
News
BioNTech erhält BMBF-Förderung von bis zu 375 Millionen Euro für COVID-19-Impfstoffprogramm BNT162
News
BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162
News
Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing
News
Pfizer und BioNTech geben Vereinbarung mit dem Vereinigten Königreich über 30 Millionen Dosen eines mRNA-basierten Impfstoffkandidaten gegen SARS-CoV-2 bekannt
News
Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
News
BioNTech kündigt öffentliche Angebote von American Depositary Shares an
News
BioNTech Announces Proposed Public Offerings
News
BioNTech gibt Preisfestsetzung für das aufgestockte Zeichnungsangebot und die Konditionen des Bezugsrechtsangebots bekannt
Pagination
Previous page
‹‹
Page 2
Next page
››